Latin America Hemodynamic Monitoring System Market Growth, Key Manufacturers Analysis and Regional Forecast 2019-2029

This Latin America Hemodynamic Monitoring System Market Report gives information about the brand awareness, market landscape, possible future issues, industry trends and customer behaviour for the Healthcare IT industry. A team of enthusiastic, dynamic and skilled researchers and analysts work with full dedication to provide our clients with the supreme market research report. The market drivers and restraints have also been explained using SWOT analysis. This comprehensive report makes available the recent and forthcoming technical and financial details of the industry. A thorough market report like this Latin America Hemodynamic Monitoring System Market Report truly acts as a backbone for the success of any business.

Hemodynamic monitoring system is used for the blood pressure and blood flow measurements inside the veins, heart, and arteries to see how well the heart is working. The hemodynamic monitoring system have various applications in monitoring of heart continuous cardiac output (CCO), pulse pressure variation (PPV), mean arterial pressure (MAP), systemic vascular resistance (SVR),  stroke volume (SV), stroke volume variation (SVV), central venous pressure (CVP), right atrial pressure (RAP), pulmonary artery occlusion pressure (PAOP), pulmonary artery catheters (PAC) and central venous catheters (CVC). Various companies are engaged in manufacturing the hemodynamic monitoring system such as Edwards Lifesciences Corporation, Getinge Ab, ICU Medical, Inc., Cheetah Medical Inc, Drägerwerk Ag & Co. KGAA., Lidco Group among others.

Download Free Sample copy of this Report:

The continuous development in hemodynamic monitoring system for cardiovascular diseases monitoring and increasing geriatric population demand for clinical care is driving the Latin America hemodynamic monitoring system market. The Technological advancement in the hemodynamic monitoring system is leading the major manufactures to expand their business for the development and production of hemodynamic monitoring system. For instance, In April, 2019 LiDCO (UK) expanded their business in South Korea by taking approvals form Korean ministry of food & drug safety for its hemodynamic monitoring product commercial sale. Latin America hemodynamic monitoring system market is projected to register a healthy CAGR of 6.6% in the forecast period 2019 to 2026.

Competitive Analysis: Latin America Hemodynamic Monitoring System Market

Some of the major players operating in this market Edwards Lifesciences Corporation, Getinge Ab , Icu Medical, Inc., Cheetah Medical Inc, Drägerwerk Ag & Co. Kgaa., Lidco, Cnsystems Medizintechnik Gmbh, Fujiflims Corporation  , General Electric Company, Koninklijke Philips N.V., Ni Medical, Osypka Medical Gmbh, Uscom among others.

Table of Content:

01: Executive Summary

02: Scope of The Report

03: Market Landscape

04: Market Sizing

05: Market Segmentation by Product

06: Five Forces Analysis

07: Customer Landscape

08: Geographic Landscape

09: Decision Framework

10: Drivers and Challenges

11: Market Trends

12: Vendor Landscape

13: Vendor Analysis

Table of Contents Available For this Market Download Free TOC :

Segmentation: Latin America Hemodynamic Monitoring System Market

Latin America hemodynamic monitoring system market is segmented into four notable segments which are type, product, end user and distribution channel.

  • On the basis of type, the market is segmented into invasive hemodynamic monitoring system, non-invasive hemodynamic monitoring system, and minimally-invasive hemodynamic monitoring system . The non-invasive hemodynamic monitoring at the highest CAGR of 6.9% in the forecast period of 2019 to 2026.
    • In July 2017, LiDCO (UK) launched its new slim widescreen monitor platform, LiDCOunity v2. This new monitor brings together LiDCO’s non-invasive, minimally invasive and calibrated hemodynamic monitoring all on one platform.
  • On the basis of product, the market is segmented into visualization monitors, analyzers, catheter, pressure monitoring devices, monitoring sensors, accessories, recording system, software, others. Catheter segment is growing at the highest CAGR of 7.7% in the forecast period of 2019 to 2026.
  • CNSystems Medizintechnik GmbH (Austria), offers a Task Force Monitor which is designed for continuous non-invasive hemodynamic and autonomic assessment. It allows continuous measurement of blood pressure, beat-to-beat cardiac output, bio receptor sensitivity. It helps in investigation of syncope, orthostatic hypotension and autonomic function tests. it is used in the clinical and research purposes.
  • On the basis of end user, the market is segmented into hospitals and clinics, catheterization labs, ambulatory surgical centers, home care settings, research institutions and academy. Hospitals and clinics segment is growing at the highest CAGR of 7.1% in the forecast period of 2019 to 2026.
    • Edwards Lifescience Corporation (US) provides ClearSight system it gives more clear insight to make decision about high-risk surgery. It is designed to use in perioperative goal-directed therapy. It can be used to monitor stroke volume (SV), cardiac output (CO), continuous blood pressure (CBP), Stroke volume variation (SVV), and systemic vascular resistance (SVR) valuable hemodynamic insight in moderate to high-risk surgery.
  • On the basis of Distribution Channel, the market is segmented into direct tender and retailer. Direct tender is growing at the highest CAGR of 6.84 % in the forecast period of 2019 to 2026.
    • In March 2019, Uscom (Australia) Uscom took approval from National Medical Products Administration (NMPA) for Type II Medical Devices sale in China. By this approval the company will directly sell type II medical devices that includes Uscom BP+, USCOM 1A, and Spiro Sonic digital ultrasonic spirometers through Uscom China.

Recent Developments:

  • In April, 2019 Edwards Lifesciences Corporation (US) completes acquisition of CAS Medical Systems, Inc. (US). CAS Medical Systems, Inc. a medical technology organization that is dedicated for non-invasive brain and tissue oxygenation monitoring. This will acquisition will provide unique offering of enhanced recovery tools for clinicians.
  • In February 2018, Getinge (Sweden) the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to its PulsioFlex monitoring system and PiCCO Module. The PulsioFlex is a hemodynamic monitoring system providing cardiac output. This approval will expand Getinge Business.
  • In June 2018, Cheetah Medical (US) collaborated with SEBAC SA (France) for supply of starling SV monitoring systems to Paris’ public hospital system. It is a hemodynamic monitoring system that gives non-invasive dynamic assessments. this will Expand Cheetah Medical business in France.
  • In October 2018, DELTEX MEDICAL (UK )launched TrueVue at Anesthesiology Society of America (ASA) annual congress. TrueVue is designed to delivers an unparalleled and unprecedented view of the haemodynamic status.This will provide real time, directly monitoring cardiac output data keeping patient’s in their optimum range.
  • In January 2019, DELTEX MEDICAL (UK) got recommendation from The National Institute for Health and Care Excellence (UK) for its oesophageal Doppler monitoring (ODM). ODM monitors stroke volume and Cardiac Output during surgical intervention. This recommendation will help to improve Deltex’s business.
  • In February, 2019 Philips collaborated with Microsoft Corporation (US) to Showcase Augmented Reality for Image-Guided Minimally Invasive Therapies. This system helps in improving the workflow and navigation in the cath lab. With the help of this, the physician can view and interact with true 3-D holograms of anatomy and view things like hemodynamic data.
  • In October, 2018 NI MEDICAL (Israel) collaborated with CHF Solutions, Inc, (U.S.) to potentially explore clinical synergies between Aquadex FlexFlow system and NICaS hemodynamic to examine between fluid volume and hemodynamic parameters in patients during ultrafiltration process. This collaboration leads to access the technology and advance treatment of patients through fluid overload.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. 

To Inquire before Buy Complete Report Click Here @

Contact: Data Bridge Market Research

Tel: +1-888-387-2818


About Data Bridge Market Research 14413 Articles
Hi, I am Ravi Kumar, a Blogger, Freelancer, SEO Consultant, an Internet Marketer, I am a research analyst who loves to evaluate data relating to Manufacturing industry, Management of companies and enterprises, Finance and insurance, Wholesale trade, Management, scientific, and technical consulting services

Leave a Reply

Your email address will not be published.